CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 240 enrolled
Drug / intervention
Lutein +1 moredrug
Likely dose
Lutein 12mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00346333
NCT00346333Phase 3Completed
CompareCT.gov

Randomized Clinical Trial for Retinitis Pigmentosa

National Eye Institute (NEI)·interventional·Posted Jun 29, 2006·Updated Jan 31, 2014

In Brief

A Phase 3 clinical trial evaluating Lutein and Cornstarch control for Retinitis Pigmentosa. Completed, enrolled 240 participants across 1 site.

Detailed Summary

The purpose of this trial is to determine whether lutein in addition to vitamin A will slow the course of retinitis pigmentosa.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRetinitis Pigmentosa
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 29, 2006
Enrollment StartJul 1, 2003
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 20.0 years ago

Interventions

Luteindrug

12mg/d

Cornstarch controldietary

Daily intake of cornstarch control plus 15,000 IU/d Vitamin A palmitate